35 studies found for:    " August 29, 2007":" September 28, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies
Conditions: Chronic Hepatitis C;   HIV Infections
Intervention: Drug: Peginterferon alfa-2a plus ribavirin adjusted to body weight
22 Completed
Has Results
Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)
Condition: HIV Infections
Interventions: Drug: darunavir 800 mg;   Drug: FTC 200 mg/TDF 300mg;   Drug: Maraviroc;   Drug: Raltegravir;   Drug: Ritonavir 100 mg
23 Completed Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
Condition: HIV Infections
Interventions: Drug: tenofovir + emtricitabine + efavirenz;   Drug: tenofovir + emtricitabine + lopinavir-ritonavir;   Drug: tenofovir + emtricitabine + atazanavir-ritonavir
24 Completed
Has Results
A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).
Condition: HIV-1 Infection
Intervention: Drug: TMC125; darunavir; ritonavir
25 Completed
Has Results
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
Conditions: Genital Herpes;   HIV Infection
Interventions: Drug: valacyclovir;   Drug: acyclovir
26 Completed
Has Results
Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects
Condition: HIV Infections
Intervention: Drug: raltegravir
27 Completed TMC 125 Blood Levels Study
Condition: HIV Infections
Interventions: Drug: TMC125 once daily;   Drug: TMC125 twice daily
28 Completed Switching From PI to RALtegravir in HIV Stable Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: boosted PI
29 Completed Raltegravir Insulin Sensitivity Study
Condition: HIV Infections
Interventions: Drug: Raltegravir then lopinavir/ritonavir;   Drug: Lopinavir/ritonavir then raltegravir
30 Completed
Has Results
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Tipranavir;   Drug: Etravirine;   Drug: Maraviroc
31 Terminated Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: efavirenz
32 Completed
Has Results
Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Ritonavir
33 Completed
Has Results
Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
34 Completed
Has Results
RAL-eve Study: Raltegravir Substitution Study
Condition: HIV Infections
Intervention: Drug: Raltegravir
35 Completed
Has Results
Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)
Condition: HIV Infections
Interventions: Drug: tenofovir DF 300 mg QD;   Drug: emtricitabine 200 mg QD;   Drug: Nevirapine 200 mg BID;   Drug: Atazanavir 300 mg;   Drug: Ritonavir 100 mg

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years